Factors Associated with HPV Genital Warts: A Self-Reported Cross-Sectional Study among Students and Staff of a Northern University in Nigeria
Abstract
:1. Introduction
2. Motivation—Problem Definition
3. Methods and Materials
3.1. Study Design and Setting
3.1.1. Sample Size
3.1.2. Sampling Method
3.1.3. Study Instrument and Data Collection
3.1.4. Study Variables
3.2. Data Analysis
3.3. Ethical Considerations
4. Results
4.1. Demographic Characteristics of the Study
4.2. Information about HPV and Sexual Health of Participants
4.3. The Participants’ Knowledge about the Association between Early Sex and HPV-16 and -18 Genotypes
4.4. Association between HPV Infection and Participants’ Profile
4.5. Factors Associated with HPV Genital Warts Infection among Students, Non-Academic Staff, and Academic Staff in North-Central Nigeria
5. Discussion
5.1. Study Strength and Limitations
5.2. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Omone, O.M.; Kozlovszky, M. HPV and Cervical Cancer Screening Awareness: A Case-control Study in Nigeria. In Proceedings of the 2020 IEEE 24th International Conference on Intelligent Engineering Systems (INES), Reykjavík, Iceland, 8–10 July 2020; pp. 145–152. [Google Scholar] [CrossRef]
- Emeribe, A.U.; Abdullahi, I.N.; Etukudo, M.H.; Isong, I.K.; Emeribe, A.O.; Nwofe, J.O.; Umeozuru, C.M.; Shuaib, B.I.; Ajagbe, O.R.O.; Dangana, A.; et al. The pattern of human papillomavirus infection and genotypes among Nigerian women from 1999 to 2019: A systematic review. Ann. Med. 2021, 53, 944–959. [Google Scholar] [CrossRef] [PubMed]
- Manga, M.M.; Fowotade, A.; Abdullahi, Y.M.; El-nafaty, A.U.; Adamu, D.B.; Pindiga, H.U.; Bakare, R.A.; Osoba, A.O. Epidemiological patterns of cervical human papillomavirus infection among women presenting for cervical cancer screening in North-Eastern Nigeria. Infect. Agents Cancer 2015, 10, 39. [Google Scholar] [CrossRef] [PubMed]
- Ramogola-Masire, D.; Luckett, R.; Dreyer, G. Progress and challenges in human papillomavirus and cervical cancer in southern Africa. Curr. Opin. Infect. Dis. 2022, 35, 49–54. [Google Scholar] [CrossRef] [PubMed]
- Louie, K.S.; de Sanjose, S.; Mayaud, P. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: A comprehensive review. Trop. Med. Int. Health 2009, 14, 1287–1302. [Google Scholar] [CrossRef] [PubMed]
- Cosmas, N.T.; Nimzing, L.; Egah, D.; Famooto, A.; Adebamowo, S.N.; Adebamowo, C.A. Prevalence of vaginal HPV infection among adolescent and early adult girls in Jos, North-Central Nigeria. BMC Infect. Dis. 2022, 22, 340. [Google Scholar] [CrossRef] [PubMed]
- Omone, O.M.; Gbenimachor, A.U.; Kovács, L.; Kozlovszky, M. Knowledge Estimation with HPV and Cervical Cancer Risk Factors Using Logistic Regression. In Proceedings of the 2021 IEEE 15th International Symposium on Applied Computational Intelligence and Informatics (SACI), Timisoara, Romania, 19–21 May 2021; pp. 000381–000386. [Google Scholar] [CrossRef]
- McBride, K.R.; Singh, S. Predictors of Adults’ Knowledge and Awareness of HPV, HPV-Associated Cancers, and the HPV Vaccine: Implications for Health Education. Health Educ. Behav. 2018, 45, 68–76. [Google Scholar] [CrossRef] [PubMed]
- What Are the Different Types of Vaccines? News-Medical.net, 28 July 2020. Available online: https://www.news-medical.net/health/What-are-the-Different-Types-of-Vaccines.aspx(accessed on 2 November 2022).
- CDC. Enhanced Immunity; Centers for Disease Control and Prevention: Atlanta, GA, USA, 21 January 2022. Available online: https://www.cdc.gov/healthy-weight-growth/about/enhancing-immunity.html?CDC_AAref_Val=https://www.cdc.gov/nccdphp/dnpao/features/enhance-immunity/index.html (accessed on 2 November 2022).
- Song, D.; Li, H.; Li, H.; Dai, J. Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer. Oncol. Lett. 2015, 10, 600–606. [Google Scholar] [CrossRef] [PubMed]
- Childs, C.E.; Calder, P.C.; Miles, E.A. Diet and Immune Function. Nutrients 2019, 11, 1933. [Google Scholar] [CrossRef] [PubMed]
- Brown, B.; Folayan, M. Barriers to uptake of human papilloma virus vaccine in Nigeria: A population in need. Niger. Med. J. 2015, 56, 301. [Google Scholar] [CrossRef]
- Musa, J.; Nankat, J.; Achenbach, C.J.; Shambe, I.H.; Taiwo, B.O.; Mandong, B.; Daru, P.H.; Murphy, R.L.; Sagay, A.S. Cervical cancer survival in a resource-limited setting-North Central Nigeria. Infect. Agents Cancer 2016, 11, 15. [Google Scholar] [CrossRef]
- Bruni, L.; Albero, G.; Serrano, B.; Mena, M.; Collado, J.J.; Gómez, D.; Muñoz, J.; Bosch, F.X.; de Sanjosé, S. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Nigeria. Summary Report 22 October 2021.pdf. Available online: https://hpvcentre.net/statistics/reports/NGA.pdf (accessed on 11 November 2022).
- CDC. Immunization Schedules for 18 & Younger; Centers for Disease Control and Prevention: Atlanta, GA, USA, 17 February 2022. Available online: https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html (accessed on 4 November 2022).
- Ahonkhai, A.A.; Odusanya, O.O.; Meurice, F.P.; Pierce, L.J.; Durojaiye, T.O.; Alufohai, E.F.; Clemens, R.; Ahonkhai, V.I. Lessons for strengthening childhood immunization in low- and middle-income countries from a successful public-private partnership in rural Nigeria. Int. Health 2022, 14, 632–638. [Google Scholar] [CrossRef] [PubMed]
- National Cancer Institute (NCI). Epidemiologic and Molecular Features of Cervical Cancer in Nigeria-Project Itoju (Care). Available online: https://clinicaltrials.gov/ct2/show/NCT00804466 (accessed on 9 November 2022).
- Beszédes, B.; Széll, K.; Györök, G. A Highly Reliable, Modular, Redundant and Self-Monitoring PSU Architecture. Acta Polytech. Hung. 2020, 17, 233–249. [Google Scholar] [CrossRef]
- Brisson, M.; Kim, J.J.; Canfell, K.; Drolet, M.; Gingras, G.; Burger, E.A.; Martin, D.; Simms, K.T.; Bénard, É.; Boily, M.-C.; et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: A comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet 2020, 395, 575–590. [Google Scholar] [CrossRef] [PubMed]
- Australia, C. What Are the Risk Factors for Cervical Cancer? 18 December 2019. Available online: https://www.canceraustralia.gov.au/cancer-types/cervical-cancer/awareness (accessed on 10 March 2022).
- Cervical Cancer. Available online: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer (accessed on 14 March 2022).
- Law in Nigeria—DLA Piper Global Data Protection Laws of the World. Available online: https://www.dlapiperdataprotection.com/index.html?t=law&c=NG (accessed on 8 August 2022).
- Schnatz, P.F.; Markelova, N.V.; Holmes, D.; Mandavilli, S.R.; O’Sullivan, D.M. The prevalence of cervical HPV and cytological abnormalities in association with reproductive factors of rural Nigerian women. J. Womens Health 2008, 17, 279–285. [Google Scholar] [CrossRef] [PubMed]
- Garai-Fodor, M. The Impact of the Coronavirus on Competence, from a Generation-Specific Perspective. Acta Polytech. Hung. 2022, 19, 111–125. [Google Scholar] [CrossRef]
- Uthman, O.A. Does it really matter where you live? A multilevel analysis of social disorganization and risky sexual behaviours in sub-Saharan Africa. In DHS Working Papers; ICF Macro: Calverton, MD, USA, 2010; pp. 1–29. [Google Scholar]
- Menon, J.A.; Mwaba, S.O.C.; Thankian, K.; Lwatula, C. Risky sexual behaviour among university students. Int. STD Res. Rev. 2016, 4, 1–7. [Google Scholar] [CrossRef]
- Jain, M.N.; Karnad, V. Online Forms for Data Collection and its Viability in Fashion and Consumer Buying Behavior Survey—A Case Study. ESSENCE—International Journal for Environmental Rehabilitation and Conservation 2017, Volume 8: Special No. 1, 66–71. ISSN 0975-6272. Available online: https://www.academia.edu/32807943/Online_Forms_for_Data_Collection_and_its_Viability_in_Fashion_and_Consumer_Buying_Behavior_Survey_A_Case_Study (accessed on 20 August 2017).
- Ntoimo, L.F.C.; Akokuwebe, M.E. Prevalence and Patterns of Marital Dissolution in Nigeria. NJSA 2014, 12. [Google Scholar] [CrossRef]
- SUNAN ABU-DAWUD, Book 6: Divorce (Kitab Al-Talaq). Available online: https://www.iium.edu.my/deed/hadith/abudawood/006_sat.html (accessed on 18 November 2022).
- Oguntayo, O.; Zayyan, M.; Kolawole, A.; Adewuyi, S.; Ismail, H.; Koledade, K. Cancer of the cervix in Zaria, Northern Nigeria. Ecancermedicalscience 2011, 5, 219. [Google Scholar] [CrossRef] [PubMed]
- Toye, M.A.; Okunade, K.S.; Roberts, A.A.; Salako, O.; Oridota, E.S.; Onajole, A.T. Knowledge, perceptions and practice of cervical cancer prevention among female public secondary school teachers in Mushin local government area of Lagos State, Nigeria. Pan Afr. Med. J. 2017, 28, 221. [Google Scholar] [CrossRef]
- Makwe, C.C.; Anorlu, R.I.; Odeyemi, K.A. Human papillomavirus (HPV) infection and vaccines: Knowledge, attitude and perception among female students at the University of Lagos, Lagos, Nigeria. JEGH 2012, 2, 199. [Google Scholar] [CrossRef]
- Adebamowo, S.N.; Olawande, O.; Famooto, A.; Dareng, E.O.; Offiong, R.; Adebamowo, C.A. Persistent Low-Risk and High-Risk Human Papillomavirus Infections of the Uterine Cervix in HIV-Negative and HIV-Positive Women. Front. Public Health 2017, 5, 178. [Google Scholar] [CrossRef] [PubMed]
- Bolarinwa, O.A.; Ajayi, K.V.; Sah, R.K. Association between knowledge of Human Immunodeficiency Virus transmission and consistent condom use among sexually active men in Nigeria: An analysis of 2018 Nigeria Demographic Health Survey. PLoS Glob. Public Health 2022, 2, e0000223. [Google Scholar] [CrossRef] [PubMed]
- Nike Adebowale-Tambe Only 34% of Nigerians Use Condoms–Survey: Premiunmtimesng. 2020. Available online: https://www.premiumtimesng.com/health/health-news/377202-only-34-of-nigerians-use-condoms-survey.html (accessed on 18 November 2022).
- Folayan, M.O.; Odetoyinbo, M.; Brown, B.; Harrison, A. Differences in sexual behaviour and sexual practices of adolescents in Nigeria based on sex and self-reported HIV status. Reprod. Health 2014, 11, 83. [Google Scholar] [CrossRef] [PubMed]
- Enebe, J.T.; Enebe, N.O.; Agunwa, C.C.; Nduagubam, O.C.; Okafor, I.I.; Aniwada, E.C.; Aguwa, E.N. Awareness, acceptability and uptake of cervical cancer vaccination services among female secondary school teachers in Enugu, Nigeria: A cross-sectional study. Pan Afr. Med. J. 2021, 39, 62. [Google Scholar] [CrossRef] [PubMed]
- Akarolo-Anthony, S.N.; Famooto, A.O.; Dareng, E.O.; Olaniyan, O.B.; Offiong, R.; Wheeler, C.M.; Adebamowo, C.A. Age-specific prevalence of human papilloma virus infection among Nigerian women. BMC Public Health 2014, 14, 656. [Google Scholar] [CrossRef] [PubMed]
- Kero, K.M.; Rautava, J.; Syrjänen, K.; Kortekangas-Savolainen, O.; Grenman, S.; Syrjänen, S. Stable marital relationship protects men from oral and genital HPV infections. Eur. J. Clin. Microbiol. Infect. Dis. 2014, 33, 1211–1221. [Google Scholar] [CrossRef]
- Iliyasu, Z.; Galadanci, H.S.; Muhammad, A.; Iliyasu, B.Z.; Umar, A.A.; Aliyu, M.H. Correlates of human papillomavirus vaccine knowledge and acceptability among medical and allied health students in Northern Nigeria. J. Obstet. Gynaecol. 2022, 42, 452–460. [Google Scholar] [CrossRef] [PubMed]
- Vahle, K.; Gargano, J.W.; Lewis, R.M.; Querec, T.D.; Unger, E.R.; Bednarczyk, R.A.; Markowitz, L.E. Prevalence of Human Papillomavirus Among Women Older than Recommended Age for Vaccination by Birth Cohort, United States 2003–2016. J. Infect. Dis. 2022, 225, 94–104. [Google Scholar] [CrossRef]
- Okunade, K.S.; Nwogu, C.M.; Oluwole, A.A.; Anorlu, R.I. Prevalence and risk factors for genital high-risk human papillomavirus infection among women attending the out-patient clinics of a university teaching hospital in Lagos, Nigeria. Pan Afr. Med. J. 2017, 28, 227. [Google Scholar] [CrossRef]
Variables | Frequency (n = 1860) | Percent (%) |
---|---|---|
Gender | ||
Male | 110 | 5.9 |
Female | 1750 | 94.1 |
Age | ||
15–25 | 151 | 8.1 |
26–40 | 1512 | 81.3 |
41–64 | 197 | 10.6 |
Education | ||
High School/Equivalent | 136 | 7.3 |
BSc, MSc, Doctorate Degree | 1724 | 92.7 |
Income (USD) | ||
Below 100 | 739 | 39.7 |
100–200 | 509 | 27.4 |
Above 200 | 612 | 32.9 |
Marital status | ||
Currently married | 1369 | 73.6 |
Not in a sexually active relationship (Single/Divorced) | 491 | 26.4 |
Variables | Frequency (n = 1860) | Percent (%) |
---|---|---|
Have you ever had sex? | ||
Yes | 1843 | 99.1 |
No | 17 | 0.9 |
Age at first sexual intercourse (n = 1843) | ||
15–20 | 911 | 49.4 |
21–30 | 875 | 47.5 |
31 and above | 57 | 3.1 |
Number of sexual partners in lifetime (n = 1843) | ||
1 sexual partner in a lifetime | 569 | 30.9 |
2–4 sexual partners in a lifetime | 636 | 34.5 |
>4 sexual partners in a lifetime | 638 | 34.6 |
Protected sex (n = 1274) | ||
Unprotected sex | 934 | 73.3 |
Protected sex | 340 | 26.7 |
Kind of sex practiced (n = 1843) | ||
Vaginal sex | 1790 | 97.1 |
Others (anal, oral, vaginal) | 53 | 2.9 |
HPV seminar | ||
No | 1332 | 71.6 |
Yes | 528 | 28.4 |
Ever received HPV vaccine? | ||
No | 1753 | 94.2 |
Yes | 107 | 5.8 |
Medical record of HPV-16 and -18 genotypes | ||
No | 1805 | 97.0 |
Yes | 55 | 3.0 |
Medical record of HPV genital warts infection | ||
No | 1786 | 96.0 |
Yes | 74 | 4.0 |
Self-Reported HPV Infection | ||||
---|---|---|---|---|
Variables | No | Yes | Test Statistics (Chi-Square/Fisher’s Exact) | p-Value |
Gender | 0.67 | 0.414 | ||
Male | 104(94.5) | 6(5.5) | ||
Female | 1682(96.1) | 68(3.9) | ||
Age | 9.85 | 0.007 ** | ||
15–25 | 138(91.4) | 13(8.6) | ||
26–40 | 1456(96.3) | 56(3.7) | ||
41–64 | 192(97.5) | 5(2.5) | ||
Education | 0.04 | 0.852 | ||
Elementary School and High School | 131(96.3) | 5(3.7) | ||
BSc, MSc, Doctorate Degree | 1655(96.0) | 69(4.0) | ||
Income | 1.41 | 0.495 | ||
Below 100 | 706(95.5) | 33(4.5) | ||
100–200 | 493(96.9) | 16(3.1) | ||
Above 200 | 587(95.9) | 25(4.1) | ||
Marital status | 4.07 | 0.045 | ||
Married | 1322(96.6) | 47(3.4) | ||
Not in a sexually active relationship (single/divorced) | 464(94.5) | 27(5.5) | ||
Have you ever had sexual intercourse? | 0.71 | 0.645 | ||
No | 17(100.0) | 0(0.0) | ||
Yes | 1769(96.0) | 74(4.0) | ||
Age at first sexual intercourse | 1.07 | 0.585 | ||
15–20 | 876(96.2) | 35(3.8) | ||
21–30 | 837(95.7) | 38(4.3) | ||
≥31 | 56(98.2) | 1(1.8) | ||
Number of sexual partners in lifetime | 3.4 | 0.182 | ||
1 sexual partner in a lifetime | 553(97.2) | 16(2.8) | ||
2–4 sexual partners in a lifetime | 609(95.8) | 27(4.2) | ||
≥4 sexual partners in a lifetime | 607(95.1) | 31(4.9) | ||
Protected sex | 2.77 | 0.096 * | ||
Unprotected sex | 886(94.9) | 48(5.1) | ||
Protected sex | 330(97.1) | 10(2.9) | ||
Kind of sex practiced | 4.97 | 0.083 * | ||
Vaginal sex only | 1721(96.1) | 69(3.9) | ||
Others (anal, oral, vaginal) | 48(90.6) | 5(9.4) | ||
HPV seminar | 0.28 | 0.600 | ||
No | 1281(96.2) | 51(3.8) | ||
Yes | 505(95.6) | 23(4.4) | ||
Knowledge about HPV-16 and -18 genotype | 12.44 | 0.000 ** | ||
No | 1651(96.5) | 60(3.5) | ||
Yes | 135(90.6) | 14(9.4) | ||
HPV vaccine? | 1.95 | 0.162 | ||
No | 1686(96.2) | 67(3.8) | ||
Yes | 100(93.5) | 7(6.5) | ||
Knowledge about early sex | 4.89 | 0.027 ** | ||
No | 1005(96.9) | 32(3.1) | ||
Yes | 781(94.9) | 42(5.1) |
Self-Reported HPV Genital Warts | Odds Ratio | 95% CI | p-Value | ||
---|---|---|---|---|---|
Lower | Upper | ||||
Gender | |||||
Male | ref | ||||
Female | 0.80 | 0.32 | 1.99 | 0.630 | |
Age | |||||
15–25 | ref | ||||
26–40 | 0.45 | 0.22 | 0.89 | 0.024 | |
41–64 | 0.31 | 0.10 | 0.95 | 0.041 | |
Marital status | |||||
Married | ref | ||||
Not in a sexually active relationship (Single/Divorced) | 1.39 | 0.81 | 2.40 | 0.233 | |
Kind of sex practiced | |||||
Vaginal sex | ref | ||||
Others (anal, oral, vaginal) | 2.13 | 0.77 | 5.84 | 0.143 | |
Protected sex | |||||
Unprotected sex | ref | ||||
Protected sex | 0.59 | 0.32 | 1.09 | 0.095 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ogbolu, M.O.; Eniade, O.D.; Majiya, H.; Kozlovszky, M. Factors Associated with HPV Genital Warts: A Self-Reported Cross-Sectional Study among Students and Staff of a Northern University in Nigeria. Viruses 2024, 16, 902. https://doi.org/10.3390/v16060902
Ogbolu MO, Eniade OD, Majiya H, Kozlovszky M. Factors Associated with HPV Genital Warts: A Self-Reported Cross-Sectional Study among Students and Staff of a Northern University in Nigeria. Viruses. 2024; 16(6):902. https://doi.org/10.3390/v16060902
Chicago/Turabian StyleOgbolu, Melvin Omone, Olanrewaju D. Eniade, Hussaini Majiya, and Miklós Kozlovszky. 2024. "Factors Associated with HPV Genital Warts: A Self-Reported Cross-Sectional Study among Students and Staff of a Northern University in Nigeria" Viruses 16, no. 6: 902. https://doi.org/10.3390/v16060902
APA StyleOgbolu, M. O., Eniade, O. D., Majiya, H., & Kozlovszky, M. (2024). Factors Associated with HPV Genital Warts: A Self-Reported Cross-Sectional Study among Students and Staff of a Northern University in Nigeria. Viruses, 16(6), 902. https://doi.org/10.3390/v16060902